{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-112644","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.263886+00:00","generated_at":"2026-05-16T19:46:59.395750+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NanoViricides raises $6M in registered direct offering and private placement with warrants","bullets":["Offered 3,571,429 shares (or pre-funded equivalents) at $1.68/share for gross proceeds of ~$6M.","Concurrent private placement of Series A warrants (3.57M shares, $1.75 exercise, 2yr) and Series B warrants (3.57M shares, $2.00 exercise, 5.5yr).","Offering closed Nov 12, 2025; net proceeds for working capital and general corporate purposes.","Directors and executive officers entered into 90-day lock-up agreements following closing.","A.G.P./Alliance Global Partners acted as sole placement agent with 7% cash fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-112644","json":"https://secwatch.observer/filing/0001104659-25-112644.json","markdown":"https://secwatch.observer/filing/0001104659-25-112644.md","text":"https://secwatch.observer/filing/0001104659-25-112644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465925112644/0001104659-25-112644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465925112644/tm2531119d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:46:59.395750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c338fd0ff1ea2e0f4e1577d732ab2dcd98ffef3","claim":"NANOVIRICIDES, INC. issued Series A Common Stock Purchase Warrants to purchase up to 3,571,429 shares of Common Stock and Series B Common Stock Purchase Warrants to purchase up to 3,571,4 of warrant to a certain institutional investor.","evidence_excerpt":"The information contained above in Item 1.01 relating to the issuance of the Common Warrants and the shares of Common Stock issuable thereunder is hereby incorporated by reference into this Item 3.02.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1379006/000110465925112644/0001104659-25-112644-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"Series A Common Stock Purchase Warrants to purchase up to 3,571,429 shares of Common Stock and Series B Common Stock Purchase Warrants to purchase up to 3,571,4"},{"label":"Purchaser","value":"a certain institutional investor"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}